Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-28

Clinical Trial Update: Hyaluronic Acid in Acute Exacerbation of COPD - Duration Of Noninvasive Assistance [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating hyaluronic acid for acute exacerbation of chronic obstructive pulmonary disease (COPD); study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyaluronic acid (hyaluronic acid)

Snippet

Sponsor: Campus Bio-Medico University | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED